Status:

COMPLETED

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Lead Sponsor:

Merit E. Cudkowicz, MD

Collaborating Sponsors:

Biohaven Pharmaceuticals, Inc.

Conditions:

Amyotrophic Lateral Sclerosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen B will evaluat...

Detailed Description

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. This trial is designed ...

Eligibility Criteria

Inclusion

  • No additional inclusion criteria beyond the inclusion criteria specified in the Master Protocol (NCT NCT04297683).

Exclusion

  • The following exclusion criteria are in addition to the exclusion criteria specified in the Master Protocol (NCT NCT04297683).
  • Participants who are taking strong inhibitors of CYP1A2 (i.e., ciprofloxacin, enoxacin, fluvoxamine, zafirlukast) for chronic/long-term use defined as more than two weeks.
  • Participants who are taking strong inhibitors of CYP3A4 (i.e., conivaptan, itraconazole, ketoconazole, posaconazole, troleandomycin, voriconazole, clarithromycin, diltiazem, idelalisib, nefazodone, and certain antiviral agents \[cobicistat, danoprevir, ritonavir, elvitegravir, indinavir, lopinavir, paritaprevir, ombitasavir, dasabuvir, saquinavir, tipranavir, nelfinavir\]) for chronic/long-term use defined as more than two weeks. Note: Topical antifungal use is not exclusionary. Participants should not consume large quantities of grapefruit juice (more than 8oz per day) on a regular basis.

Key Trial Info

Start Date :

July 28 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 6 2022

Estimated Enrollment :

167 Patients enrolled

Trial Details

Trial ID

NCT04436510

Start Date

July 28 2020

End Date

December 6 2022

Last Update

June 12 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Healey Center for ALS at Mass General

Boston, Massachusetts, United States, 02114